Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | ASKG915 |
Synonyms | |
Therapy Description |
ASKG915 is an anti-PD-1/IL-15 prodrug fusion molecule that potentially induces antitumor immune activity (J Immunother Cancer 2022;10(Suppl 2):1183). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ASKG915 | ASKG 915|ASKG-915 | PD-L1/PD-1 antibody 117 | ASKG915 is an anti-PD-1/IL-15 prodrug fusion molecule that potentially induces antitumor immune activity (J Immunother Cancer 2022;10(Suppl 2):1183). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05867420 | Phase I | ASKG915 | A Study of ASKG915 in Patients With Selected Advanced Solid Tumors. | Recruiting | USA | 0 |